Correlation Between BioAffinity Technologies, and Biocept
Can any of the company-specific risk be diversified away by investing in both BioAffinity Technologies, and Biocept at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioAffinity Technologies, and Biocept into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between bioAffinity Technologies, and Biocept, you can compare the effects of market volatilities on BioAffinity Technologies, and Biocept and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioAffinity Technologies, with a short position of Biocept. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioAffinity Technologies, and Biocept.
Diversification Opportunities for BioAffinity Technologies, and Biocept
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between BioAffinity and Biocept is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding bioAffinity Technologies, and Biocept in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biocept and BioAffinity Technologies, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on bioAffinity Technologies, are associated (or correlated) with Biocept. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biocept has no effect on the direction of BioAffinity Technologies, i.e., BioAffinity Technologies, and Biocept go up and down completely randomly.
Pair Corralation between BioAffinity Technologies, and Biocept
If you would invest 145.00 in Biocept on August 29, 2024 and sell it today you would earn a total of 0.00 from holding Biocept or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 0.79% |
Values | Daily Returns |
bioAffinity Technologies, vs. Biocept
Performance |
Timeline |
bioAffinity Technologies, |
Biocept |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
BioAffinity Technologies, and Biocept Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BioAffinity Technologies, and Biocept
The main advantage of trading using opposite BioAffinity Technologies, and Biocept positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioAffinity Technologies, position performs unexpectedly, Biocept can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biocept will offset losses from the drop in Biocept's long position.BioAffinity Technologies, vs. Intelligent Bio Solutions | BioAffinity Technologies, vs. T2 Biosystms | BioAffinity Technologies, vs. Genetic Technologies | BioAffinity Technologies, vs. Psychemedics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |